Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Dec. 14, 2016, at the BMO Capital Markets 2016 Prescriptions for Success...

Thomas P. Gibbons, vice chairman and chief financial officer of BNY Mellon, Brian T. Shea, vice chairman and chief executive officer of BNY Mellon Investment Services, and Mitchell E. Harris,...

VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation therapies for depression and other central nervous system (CNS)...

Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, will present at the Raymond James Technology...

Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in...